A Swiss biotech company
based in Basel
is built upon
two main pillars.
Designing and developing best-in-class vaccines.Our expertise and technologies enable us to create vaccines that, we believe, will outperform any other commercial or in-development vaccine in several disease areas.
Developing an advanced technology platform speciﬁcally for vaccine design.Our primary goal is to leverage our reverse genetic engineering expertise to create next-generation vaccines that signiﬁcantly outperform existing options. We have carefully studied the competitive landscape and thoroughly analyzed various diseases to develop innovative vaccines using our state-of-the-art technologies, with the aim of achieving a superior market position for our products.
RocketVax utilizes proprietary reverse genetic engineering & molecular biology technologies to develop innovative, next-generation vaccines.
Our first products are
COVID-19 vaccines, which possess the following characteristics
Effectiveness against circulating & future SARS-CoV-2 variants
Needle-free, intranasal vaccine administration
Stable vaccine formulation
product overview and differentiation
Vulnerable to virus mutationsThe constantly mutating nature of SARS-CoV-2 reduces the efﬁcacy of ﬁrst-generation vaccines.
Short-term immune protectionFirst-generation vaccines induce antibodies against only the Spike protein and the protection they provide wanes rapidly.
Infection of immunized individualsFirst-generation vaccines offer poor protection against new infections and are ineffective in preventing the transmission and spread of the virus.
Limited stability at higher temperaturesThe instability of mRNA vaccines at higher temperatures necessitates complex logistics for their storage and distribution.
Resilience to virus mutationsLive-attenuated SARS-CoV-2 vaccines protect against virus variants and mutations by generating broad immune responses.
Long-lived systemic and local immunityOur vaccines provide long-lasting protection by generating antibody, T-cell, and mucosal responses against all virus proteins.
Nasal formulation prevents re-infectionOur vaccine mimics the natural route of infection through nasal vaccination, which helps prevent re-infection and limits the spread of the virus.
Stability and prolonged shelf-lifeThe stability of live-attenuated SARS-CoV-2 vaccines allows our vaccine to be stored at regular temperatures and easily distributed worldwide.
The RocketVax vaccine possesses all the characteristics necessary for successful prevention of COVID-19.